Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine + Rituximab in R/R DLBCL
NCT00831597Phase 2Completed
- Sponsor
- Pharmatech, Inc.
- Start
- Nov 2008
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in diffuse large B-cell lymphoma (DLBCL), sponsored by Pharmatech, Inc.. Started Nov 2008; status: completed.
02
Drugs
bendamustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00831597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831597.